1. Home
  2. SLGL vs DAVA Comparison

SLGL vs DAVA Comparison

Compare SLGL & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$70.00

Market Cap

247.1M

Sector

Health Care

ML Signal

HOLD

Logo Endava plc (each representing one)

DAVA

Endava plc (each representing one)

HOLD

Current Price

$3.79

Market Cap

220.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLGL
DAVA
Founded
1997
2000
Country
Israel
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
247.1M
220.4M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
SLGL
DAVA
Price
$70.00
$3.79
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$110.00
$13.50
AVG Volume (30 Days)
16.0K
298.3K
Earning Date
05-22-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$223.84
$4.07
P/E Ratio
N/A
$20.02
Revenue Growth
N/A
N/A
52 Week Low
$6.80
$3.61
52 Week High
$97.97
$16.66

Technical Indicators

Market Signals
Indicator
SLGL
DAVA
Relative Strength Index (RSI) 48.36 33.86
Support Level $67.47 N/A
Resistance Level $81.66 $7.10
Average True Range (ATR) 5.47 0.17
MACD -0.11 -0.04
Stochastic Oscillator 37.98 25.00

Price Performance

Historical Comparison
SLGL
DAVA

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About DAVA Endava plc (each representing one)

Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.

Share on Social Networks: